Michael E Yarrington

Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals

Michael E Yarrington, Deverick J. Anderson, Elizabeth Dodds Ashley et al. · Infection Control and Hospital Epidemiology · 2019 · 47 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Inappropriate<i>Clostridium difficile</i>Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics

Sean G. Kelly, Michael E Yarrington, Teresa Zembower et al. · Infection Control and Hospital Epidemiology · 2016 · 41 citations

Medicine, Infectious Diseases, Internal Medicine +16

Effects of a Collaborative, Community Hospital Network for Antimicrobial Stewardship Program Implementation

Rebekah W. Moehring, Michael E Yarrington, Angelina Davis et al. · Clinical Infectious Diseases · 2021 · 30 citations

Pharmacy, Health Administration, Health Services Administration +17

Cellular arrays for large‐scale analysis of transcription factor activity

Abigail D. Bellis, Beatriz Peňalver‐Bernabé, Michael Weiss et al. · Biotechnology and Bioengineering · 2010 · 23 citations

Life Sciences, Cell Biology, Molecular Biology +16

Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial

Rebekah W. Moehring, Michael E Yarrington, Bobby Warren et al. · Clinical Infectious Diseases · 2022 · 23 citations

Pharmacy, Internal Medicine, Antimicrobial Pharmacotherapy +16